Amy C. Sims
Science Translational Medicine · 2010–2020
A researcher in the Science corpus: 8 papers; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Papers from Amy C. Sims's perspective
Ordered by how strongly the researchers Amy C. Sims trusts endorse each paper. Same corpus, a different order for every researcher.
- Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. (New England Journal of Medicine)
- Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats. (Proceedings of the National Academy of Sciences of the United States of America)
- Characterization and Complete Genome Sequence of a Novel Coronavirus, Coronavirus HKU1, from Patients with Pneumonia (Journal of Virology)
- Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor (Nature)
- Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26 (Nature)
- Unique and Conserved Features of Genome and Proteome of SARS-coronavirus, an Early Split-off From the Coronavirus Group 2 Lineage (Journal of Molecular Biology)
- The Severe Acute Respiratory Syndrome (New England Journal of Medicine)
- Treatment With Lopinavir/Ritonavir or Interferon-β1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmoset (Journal of Infectious Diseases)
- Therapeutic Efficacy of the Small Molecule GS-5734 against Ebola Virus in Rhesus Monkeys (Nature)
- What’s new in the renin-angiotensin system?
Their papers
- Sharing and community curation of mass spectrometry data with GNPS (2016) — 3,861 citations
- Human Coronavirus HKU1 Spike Protein Uses O-Acetylated Sialic Acid as an Attachment Receptor Determinant and Employs Hemagglutinin-Esterase Protein as a Receptor-Destroying Enzyme (2015) — 236 citations
- An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice (2020) — 993 citations
- Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV (2020) — 1,642 citations
- Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease (2018) — 1,318 citations
- Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses (2017) — 1,505 citations
- SARS-like WIV1-CoV poised for human emergence (2016) — 416 citations
- Zn2+ Inhibits Coronavirus and Arterivirus RNA Polymerase Activity In Vitro and Zinc Ionophores Block the Replication of These Viruses in Cell Culture (2010) — 827 citations